GlassScriptPhysician profile
Mohammad N Zarka
NPI 1144459942
$17,938.46
in general payments reported to CMS, 2019-2025
38 companies · $2,939 in 2025
The $2,939 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,301 · 2020: $635 · 2021: $1,732 · 2022: $2,696 · 2023: $3,252 · 2024: $3,384 · 2025: $2,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,992 · Education: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,992.19 |
| Education | $581.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,091.25 | 2019-2025 | Tremfya, Stelara, Remicade |
| Abbvie INC. | $1,852.56 | 2019-2025 | Skyrizi, Rinvoq |
| Celgene Corporation | $1,695.74 | 2019 | |
| Sun Pharmaceutical Industries INC. | $1,634.62 | 2020-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $1,563.54 | 2019-2025 | |
| Lilly USA, LLC | $1,442.26 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $1,085.82 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $941.50 | 2019-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $829.18 | 2020-2025 | Nemluvio, Aklief, Oracea |
| Leo Pharma INC. | $553.01 | 2022-2025 | Adbry, Anzupgo, Spevigo |
| Ucb, INC. | $503.62 | 2019-2025 | Bimzelx |
| Amgen INC. | $457.38 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $439.55 | 2022-2025 | Sotyktu |
| Genentech USA, INC. | $281.26 | 2019-2024 | Erivedge |
| Incyte Corporation | $253.30 | 2022-2025 | Opzelura, Opzelura |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Zarka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.